SAIRA KHADERI

Concepts (153)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
13
2024
938
1.710
Why?
Liver Neoplasms
13
2024
1311
1.540
Why?
Liver Cirrhosis
13
2024
823
1.260
Why?
Liver Transplantation
6
2020
1015
0.770
Why?
Alcohol Drinking
2
2024
336
0.720
Why?
Hepatitis C
4
2023
364
0.700
Why?
Early Detection of Cancer
4
2024
348
0.640
Why?
Alcoholic Beverages
1
2019
18
0.640
Why?
End Stage Liver Disease
3
2018
178
0.640
Why?
Religion
1
2019
49
0.620
Why?
Liver Diseases
2
2018
363
0.560
Why?
Hepacivirus
3
2016
241
0.560
Why?
Alcoholism
1
2019
230
0.540
Why?
Hepatitis B virus
1
2016
136
0.500
Why?
Liver Failure, Acute
1
2016
87
0.490
Why?
Digestive System Neoplasms
1
2015
14
0.490
Why?
Cholangitis, Sclerosing
1
2015
54
0.470
Why?
alpha-Fetoproteins
2
2024
131
0.440
Why?
Hypertension, Portal
1
2014
78
0.430
Why?
Antiviral Agents
2
2016
743
0.410
Why?
Liver Diseases, Alcoholic
2
2023
57
0.410
Why?
Hypertension, Pulmonary
1
2014
434
0.330
Why?
Non-alcoholic Fatty Liver Disease
2
2023
389
0.300
Why?
Esophageal and Gastric Varices
1
2008
64
0.280
Why?
Veterans
1
2018
1733
0.280
Why?
Gastrointestinal Hemorrhage
1
2008
223
0.250
Why?
Quality Improvement
2
2022
626
0.250
Why?
Prospective Studies
10
2024
6028
0.250
Why?
Risk Factors
11
2024
10018
0.230
Why?
Phospholipases A2, Calcium-Independent
1
2024
13
0.230
Why?
Humans
27
2024
123103
0.220
Why?
Bile Acids and Salts
1
2024
234
0.200
Why?
Graft Survival
2
2014
525
0.200
Why?
Middle Aged
14
2024
25992
0.190
Why?
Hepatitis, Viral, Human
1
2020
44
0.170
Why?
Program Development
1
2020
189
0.170
Why?
United States
4
2024
10651
0.160
Why?
History, 15th Century
1
2019
14
0.160
Why?
History, Medieval
1
2019
27
0.160
Why?
History, 16th Century
1
2019
28
0.160
Why?
History, Ancient
1
2019
54
0.160
Why?
Predictive Value of Tests
3
2024
2112
0.160
Why?
Pentanoic Acids
1
2018
3
0.160
Why?
Caspase Inhibitors
1
2018
29
0.150
Why?
Fatty Liver
1
2020
177
0.150
Why?
Transition to Adult Care
1
2020
119
0.150
Why?
Cystatin C
1
2018
49
0.140
Why?
Obesity
3
2024
2230
0.140
Why?
Male
16
2024
60129
0.140
Why?
Estrogen Replacement Therapy
1
2017
44
0.140
Why?
Female
17
2024
65514
0.140
Why?
Aged
10
2024
19093
0.140
Why?
Genetic Predisposition to Disease
2
2024
3076
0.140
Why?
Genome-Wide Association Study
1
2024
1638
0.130
Why?
Risk Assessment
5
2024
3325
0.130
Why?
Sofosbuvir
1
2016
13
0.130
Why?
Patient Care Team
1
2020
548
0.130
Why?
Renal Insufficiency
1
2018
234
0.120
Why?
Gallbladder Neoplasms
1
2015
13
0.120
Why?
Hepatitis B
1
2016
159
0.120
Why?
Endpoint Determination
1
2015
53
0.120
Why?
Referral and Consultation
1
2018
529
0.120
Why?
Glomerular Filtration Rate
1
2018
481
0.120
Why?
Bile Ducts, Intrahepatic
1
2015
95
0.120
Why?
United States Department of Veterans Affairs
1
2018
657
0.120
Why?
Time Factors
2
2014
6219
0.110
Why?
Treatment Outcome
5
2018
12115
0.110
Why?
Incidence
4
2024
3039
0.110
Why?
Bile Duct Neoplasms
1
2015
109
0.110
Why?
Cholangiocarcinoma
1
2015
107
0.110
Why?
Age Factors
2
2024
2799
0.110
Why?
Administration, Inhalation
1
2014
178
0.110
Why?
Administration, Intravenous
1
2014
143
0.110
Why?
Arterial Pressure
1
2014
104
0.110
Why?
Vasodilator Agents
1
2014
203
0.100
Why?
Models, Theoretical
1
2015
356
0.100
Why?
Waiting Lists
1
2014
225
0.100
Why?
Infectious Disease Transmission, Vertical
1
2014
236
0.100
Why?
Administration, Oral
1
2014
666
0.100
Why?
Hepatitis C, Chronic
1
2016
323
0.100
Why?
Drug Therapy, Combination
1
2014
1138
0.090
Why?
Pulmonary Artery
1
2014
439
0.090
Why?
Recurrence
1
2014
1419
0.090
Why?
Retrospective Studies
5
2024
16044
0.080
Why?
Colorectal Neoplasms
1
2015
561
0.080
Why?
Texas
3
2024
3563
0.080
Why?
Genotype
1
2014
2533
0.080
Why?
Portal Pressure
1
2008
5
0.080
Why?
Decision Trees
1
2008
49
0.070
Why?
Hepatic Veins
1
2008
22
0.070
Why?
Sclerotherapy
1
2008
40
0.070
Why?
Ligation
1
2008
132
0.070
Why?
Sex Factors
2
2024
1261
0.070
Why?
Decompression, Surgical
1
2008
92
0.070
Why?
Biomarkers
3
2024
2943
0.070
Why?
Esophagoscopy
1
2008
156
0.070
Why?
Angiotensin Receptor Antagonists
1
2008
121
0.070
Why?
Biomarkers, Tumor
2
2024
1439
0.070
Why?
Serum Albumin, Human
1
2024
10
0.060
Why?
Platelet Count
1
2024
133
0.060
Why?
Serum Albumin
1
2024
107
0.060
Why?
Prothrombin
1
2024
24
0.060
Why?
Acyltransferases
1
2024
44
0.060
Why?
Bilirubin
1
2024
121
0.060
Why?
Case-Control Studies
2
2024
3234
0.060
Why?
Lipase
1
2024
88
0.060
Why?
Alanine Transaminase
1
2024
150
0.060
Why?
Liver Cirrhosis, Alcoholic
1
2023
35
0.050
Why?
Protein Precursors
1
2024
149
0.050
Why?
Adolescent
3
2020
19094
0.050
Why?
North America
1
2024
239
0.050
Why?
Genetic Loci
1
2024
332
0.050
Why?
Child, Preschool
2
2015
13888
0.050
Why?
Prognosis
2
2024
4512
0.050
Why?
Proportional Hazards Models
1
2024
1305
0.050
Why?
Adult
3
2018
29009
0.040
Why?
Overweight
1
2023
358
0.040
Why?
Severity of Illness Index
1
2008
2847
0.040
Why?
Patient Care Planning
1
2020
121
0.040
Why?
Transplant Recipients
1
2020
209
0.040
Why?
Follow-Up Studies
2
2020
5039
0.040
Why?
Keratin-18
1
2018
6
0.040
Why?
Disease Progression
1
2024
2028
0.040
Why?
Quality Indicators, Health Care
1
2020
214
0.040
Why?
Serum
1
2018
46
0.040
Why?
Patient Participation
1
2020
220
0.040
Why?
Placebos
1
2018
238
0.040
Why?
Reproducibility of Results
1
2024
2840
0.040
Why?
Child
2
2015
24228
0.040
Why?
Gastroenterology
1
2020
191
0.040
Why?
Patient Education as Topic
1
2020
449
0.040
Why?
Germ-Line Mutation
1
2019
313
0.030
Why?
Membrane Proteins
1
2024
1522
0.030
Why?
Triglycerides
1
2019
561
0.030
Why?
Sustained Virologic Response
1
2016
41
0.030
Why?
Creatinine
1
2018
380
0.030
Why?
Metabolic Syndrome
1
2019
329
0.030
Why?
Polymorphism, Single Nucleotide
1
2024
2587
0.030
Why?
Double-Blind Method
1
2018
1583
0.030
Why?
Viral Load
1
2016
381
0.030
Why?
RNA, Viral
1
2016
539
0.030
Why?
Survival Analysis
1
2017
1473
0.030
Why?
Decision Support Techniques
1
2015
280
0.020
Why?
Inflammation
1
2019
1403
0.020
Why?
Multivariate Analysis
1
2015
1413
0.020
Why?
Surveys and Questionnaires
1
2020
3664
0.020
Why?
Survival Rate
1
2015
1999
0.020
Why?
Cohort Studies
1
2019
4699
0.020
Why?
Aged, 80 and over
1
2018
6374
0.020
Why?
Young Adult
1
2020
8855
0.020
Why?
Postoperative Complications
1
2015
3011
0.010
Why?
Infant, Newborn
1
2015
8106
0.010
Why?
Infant
1
2015
12357
0.010
Why?
KHADERI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (153)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_